title: Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus.
abstract: Synthetic peptides derived from the G-H loop of the foot and mouth disease virus (FMDV) capsid protein VP1 are relatively poor at recapitulating the native conformation present in the virus, and thus are often poor immunogens. We hypothesized that a candidate mucosal vaccine against FMDV could be developed using the non-toxic Pseudomonas aeruginosa exotoxin A (ntPE) to deliver the G-H loop in its native conformation. An added benefit of this approach is the potential for ntPE to serve as an effective carrier/adjuvant molecule for delivery of the fusion protein across the epithelial barrier by virtue of its capacity to bind to CD91. A chimeric protein (ntPE-GH) was generated by inserting the coding sequence of the G-H loop into an expression plasmid encoding ntPE, in place of the native Ib loop. Recombinant ntPE-GH and wild-type ntPE were each expressed in Escherichia coli, purified over a nickel resin, then administered intranasally to the pigs, with or without the mucosal adjuvant cholera toxin (CT). Both the ntPE and ntPE-GH induced mucosal and systemic immune responses against ntPE; moreover, ntPE-GH administered without CT induced anti-GH loop serum IgG antibodies. In conclusion, these data demonstrate that ntPE can be used as a mucosal carrier/adjuvant to induce an immune response against the VP1 G-H loop of FMDV.
authors.affiliation: Department of Animal Science, University of Connecticut, Storrs, CT 06269, USA.
authors.forename: Sreerupa
authors.initials: S
authors.lastname: Challa
authors.forename: Roger
authors.initials: R
authors.lastname: Barrette
authors.forename: Debra
authors.initials: D
authors.lastname: Rood
authors.forename: John
authors.initials: J
authors.lastname: Zinckgraf
authors.forename: Richard
authors.initials: R
authors.lastname: French
authors.forename: Lawrence
authors.initials: L
authors.lastname: Silbart
mesh_terms: D036002:ADP Ribose Transferases / Q000235:genetics / Q000276:immunology*; D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001427:Bacterial Toxins / Q000235:genetics / Q000276:immunology*; D036022:Capsid Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D005098:Exotoxins / Q000235:genetics / Q000276:immunology*; D005260:Female; D029544:Foot-and-Mouth Disease Virus / Q000276:immunology*; D008297:Male; D011993:Recombinant Fusion Proteins / Q000276:immunology*; D013552:Swine; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*; D037521:Virulence Factors / Q000235:genetics / Q000276:immunology*; D000097668:Pseudomonas aeruginosa Exotoxin A
chemical_list: D036002:ADP Ribose Transferases; D000914:Antibodies, Viral; D001427:Bacterial Toxins; D036022:Capsid Proteins; D005098:Exotoxins; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A; C442501:VP1 protein, Foot-and-mouth disease virus